You are here

Article info

Article menu

Download PDFPDF

Ovarian cancer
423 Fibronectin and periostin as prognostic markers in ovarian cancer
Free

Authors

  • Katarzyna A Kujawa Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch; Center for Translational Research and Molecular Biology of Cancer PubMed articlesGoogle scholar articles
  • Ewa Zembala-Nożyńska Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch; Tumor Pathology Department PubMed articlesGoogle scholar articles
  • Alexander J Cortez Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch; Department of Biostatistics and Bioinformatics, Center for Translational Research and Molecular Biology of Cancer PubMed articlesGoogle scholar articles
  • Jolanta Kupryjańczyk Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology; Tumor Pathology Department PubMed articlesGoogle scholar articles
  • Katarzyna M Lisowska Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch; Center for Translational Research and Molecular Biology of Cancer PubMed articlesGoogle scholar articles

Citation

Kujawa KA, Zembala-Nożyńska E, Cortez AJ, et al
423 Fibronectin and periostin as prognostic markers in ovarian cancer
International Journal of Gynecologic Cancer 2020;30:A80-A81.

Publication history

  • First published December 4, 2020.
Online issue publication 
December 04, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.